Drug Profile
Research programme: CNS disorder therapeutics - Anvyl
Alternative Names: AVL 5189; AVL 8168Latest Information Update: 20 Sep 2023
Price :
$50
*
At a glance
- Originator Anvyl
- Class Steroids
- Mechanism of Action Alpha7 nicotinic acetylcholine receptor modulators; GABA A alpha 5 receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- Discontinued Brain injuries; Down syndrome; Epilepsy
Most Recent Events
- 20 Sep 2023 Discontinued - Preclinical for Brain injuries in USA (unspecified route)
- 20 Sep 2023 Discontinued - Preclinical for Down syndrome in USA (unspecified route)
- 20 Sep 2023 Discontinued - Preclinical for Epilepsy in USA (unspecified route)